Azelis · 4 days ago
US Pharma Managing Director (Remote)
United States
Full-time
Remote
Director/Executive
10+ years expAzelis is a company specializing in the Pharma market, and they are seeking a US Pharma Managing Director. This role involves defining and delivering the commercial growth agenda, building relationships with key customers, and ensuring financial performance within the US Pharma market segment.
ChemicalMedicalPharmaceutical
Responsibilities
Define and deliver the commercial growth agenda
Define the US Pharma market segment growth agenda & strategy by identifying opportunities and translating the market segment strategies into actionable targets with clear milestones, ownership, and accountability
Leverage regional and local mandates, Asia sourcing team capabilities and new business development opportunities to maximize growth
Integrate marketing, innovation, and technical services to reinforce Azelis’ specialty positioning
Deliver Principals’ market implementation plan and budget (growth, purchase value, volumes, project lists, application targets, etc.)
Lead the Customer Portfolio for US Pharma
Deploy commercial resources, skills and tools to maximize market reach/coverage at optimized cost
Build and maintain relationships with key customers, positioning Azelis as their preferred innovation and distribution partner
Expand the customer base and drive portfolio selling to create/capture cross-selling opportunities
Continuously improve commercial performance through sales effectiveness, pricing discipline, and customer segmentation
Ensure customer satisfaction through seamless service delivery
Embed data-driven decision-making across all commercial processes to enhance growth, profitability, agility, and responsiveness
Deliver Financial Performance and Key Indicators
Deliver the Sales, EBITA, Gross Profit 1 (GP1) and NWC for US Pharma market segment according to yearly budget targets
Define, monitor, and act on key financial indicators to ensure sustainable performance
Align commercial activities with financial targets, ensuring transparency and accountability
Balance topline growth and GP1% performance expectations in order to maximize GP1 growth
M&A
Build relationship with potential targets M&A
Maintain and update the M&A target list for US Pharma market segment
Contribute actively to the due diligence phase
Define and implement the best integration approach, operational efficiencies, and key milestones and metrics for acquisitions within the market segment
Contribute to the definition and take ownership of the agreed business plan. Deliver identified/expected business synergies
Attract, develop, and retain top commercial talent, fostering a culture of high performance, ownership, and entrepreneurial spirit
Optimize the commercial structure, manage and drive the US Pharma commercial leadership team to ensure successful execution
Promote engagement, accountability, and continuous learning across all levels
Lead by example, championing Azelis’ values and inspiring teams to exceed expectations
Qualification
Required
Education: Bachelor's degree in economics, Commerce or chemistry
Industry Experience: Minimum 10 years of progressive commercial leadership experience in the Pharma specialty chemicals sector. Proven track record in efficient and effective commercial execution, in strategic customer management and value-added distribution in a matrixed, multinational environment
Leadership & P&L Ownership: Proven track record in building/leading successful commercial leadership teams. Demonstrated success in driving financial performance with full P&L responsibility
Strategic Expertise: Deep knowledge of commercial strategy, customer-centric value creation, market segmentation, pricing strategies, and innovation-led growth
Commercial Excellence & Digital Fluency: Experience implementing commercial excellence frameworks and tools. Proficiency in CRM systems (e.g., D365 CRM), analytics platforms (e.g., Power BI), and digital sales enablement
Company
Azelis
Azelis is a specialty chemicals distributor.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$441.81M2025-11-12Post Ipo Secondary
2024-09-11Debt Financing· $441.81M
2021-09-17IPO
Leadership Team
Frank Bergonzi
CEO and President
Recent News
2025-11-27
2025-10-31
Company data provided by crunchbase